Brief: Ajanta Pharma Says US FDA Issues Form-483 With 5 Observations At Ajanta Pharma Paithan Facility
April 22 (Reuters) - Ajanta Pharma Ltd AJPH.NS: AJANTA PHARMA LTD - US FDA ISSUES FORM-483 WITH 5 OBSERVATIONS AT AJANTA PHARMA PAITHAN FACILITY Source text: ID:nNSE3q0qvn Further company coverage: AJPH.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ajanta Pharma
See all newsIndia's Ajanta Pharma falls as analysts say growth to moderate in H2
Brief: Ajanta Pharma Limited Sept-Quarter Consol Net Profit 3.88 Billion Rupees
India's Ajanta Pharma jumps on June quarter profit jump
Brief: Ajanta Pharma June-Quarter Consol PAT 3.34 Billion Rupees
Brief: Ajanta Pharma Receives US FDA Establishment Inspection Report For Paithan Facility